AllPennyStocks.com BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’

BioNTech said on Friday that it and its partner, Genentech, a Roche unit, are ending the mid-stage study of autogene cevumeran, used alone after surgery, in certain high-risk stage II or III colorectal cancer patients.

Other Penny Stock Movers

Fake Players Are Shaping How Games Get Reviewed; This Microcap Just Got Hired to Prove It
Copper's Real Constraint Isn't Demand. It's Ground
Colombian Oil Producer Jumps as Q2 Revenue More Than Doubles
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top